"ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan"
012221 ONO Receives a Manufacturing and
Download • 81KB
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
MedNews on financings, strategic relationships, products, services and technology, including launches
MedTalks videos featuring conversations with management of companies with business or financial objectives